NFKB1 and prostate carcinoma: Among these, the cyclic AMP response element (CRE)-binding protein (CREB), the SRY-box transcription factors (SOX), and the nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) have been characterized as regulators of gene expression influencing prostate cancer progressions [16,17,18].